AT343642B - Verfahren zur herstellung von neuen naphthalinderivaten - Google Patents
Verfahren zur herstellung von neuen naphthalinderivatenInfo
- Publication number
- AT343642B AT343642B AT501276A AT501276A AT343642B AT 343642 B AT343642 B AT 343642B AT 501276 A AT501276 A AT 501276A AT 501276 A AT501276 A AT 501276A AT 343642 B AT343642 B AT 343642B
- Authority
- AT
- Austria
- Prior art keywords
- sep
- formula
- methoxy
- oral
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical class C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 26
- 150000002790 naphthalenes Chemical class 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- -1 methoxy, methylthio Chemical group 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 5
- 230000001076 estrogenic effect Effects 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- ODKROFHKPKRFPM-UHFFFAOYSA-N 4-(6-methoxynaphthalen-2-yl)but-3-en-2-one Chemical compound C1=C(C=CC(C)=O)C=CC2=CC(OC)=CC=C21 ODKROFHKPKRFPM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
- 206010067572 Oestrogenic effect Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000011102 Thera Species 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 150000004718 beta keto acids Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LABTWGUMFABVFG-UHFFFAOYSA-N methyl propenyl ketone Chemical compound CC=CC(C)=O LABTWGUMFABVFG-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
- C07C29/145—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones with hydrogen or hydrogen-containing gases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/17—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds
- C07C29/175—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds with simultaneous reduction of an oxo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/60—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by elimination of -OH groups, e.g. by dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
- C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
- C07C33/486—Polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
- C07C45/66—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups by dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
- C07C45/676—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
- C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C49/215—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C49/217—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings
- C07C49/223—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/227—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
- C07C49/233—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
- C07C49/235—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
<Desc/Clms Page number 1> Die Erfindung bezieht sich auf ein Verfahren zur Herstellung von neuen, pharmazeutisch wirksamen Naphthalinderivaten. Es ist bekannt, dass bestimmte Naphthalinderivate wertvolle entzündungshemmende Wirksamkeitbesitzen und daher zur Behandlung von verschiedenen rheumatischen und arthritischen Zuständen verwendet werden können. Ein besonders wirksames Naphthalinderivat, das klinische Anwendung gefunden hat, ist Naxopren der Formel EMI1.1 EMI1.2 Wirksamkeiten derartiger Verbindungen sind auch in J. Med. Chem., 13,203 [1970] und J. Pham. Exp. Thera., 179,114 [1971] beschrieben. Leider wurde festgestellt, dass die Verbindung der Formel (1) bei manchen Personen in einer Dosis, die nicht wesentlich höher ist als die therapeutische Dosis, eine schwere Reizung des Magen-Darm-Traktesverursacht. Es wurde nun gefunden, dass andere Naphthalinderivate gute entzündungshemmende Wirksamkeit aufweisen, während sie in bezug auf die Magen-Darm-Reizung ein verbessertes therapeutisches Verhältnis besitzen. Derartige Verbindungen be sitzen die allgemeine Formel EMI1.3 worin X Chlor, Brom, Methoxy, Methylthio oder Alkyl mit 1 bis 4 C-Atomen bedeutet, R Wasserstoff oder EMI1.4 In derartigen Verbindungen ist X am zweckmässigsten eine Methoxy- oder Methylthiogruppe, vorzugsweise eine Methoxygruppe. Besonders geeignete Verbindungen der Formel (11) sind solche der allgemeinen Formel EMI1.5 EMI1.6 <Desc/Clms Page number 2> EMI2.1 sind, worin R die obige Bedeutung hat. Verbindungen der allgemeinen Formel (in), worin R Methyl ist, zeigen in hoher Dosis östrogene Wirkungen, wogegen solche, worin R Wasserstoff ist, derartige Wirkungen mit geringerer Wahrscheinlichkeit zeigen. Demgemäss sind bevorzugte Verbindungen 4- (6-Methoxy-2-naphthyl)-butan-2-on und 4- (6-Methoxy- - 2-naphthyl)-but-3-en-2-on. Diese beiden Verbindungen und ihre Analoga, worin das a-Kohlenstoffatom einen Methylsubstituenten trägt, zeigten eine verlängerte entzündungshemmende Wirksamkeit, als sie in einer Dosis von 100 mg/kg/Tag gemäss dem Ratten-Carrageen-Entzündungshemmungstestgeprüft wurden, jedoch den Magen in einer dreimal so hohen Dosis nicht reizten. Die Verbindungen der allgemeinen Formel (11) können entzündungshemmenden und/oder analgetischen Zusammensetzungen, die zur oralen Verabreichung an Menschen gedacht sind, einverleibt werden. Derartige Zusammensetzungen können jede übliche Form aufweisen, wie Tabletten, Kapseln, Täschchen, od. dgl. Einheitsdosisformen enthalten im allgemeinen 20 bis 100 mg, vorzugsweise 100 bis 600 mg des aktiven Bestandteiles der Formel (II). Derartige Dosierungsformen können ein-oder mehrmals täglich (vorzugsweise zwei-bis viermal täglich) eingenommen werden, so dass die tägliche Dosis für einen 70 kg schweren Menschen gewöhnlich 300 bis 3000 mg, Insbesondere 500 bis 2000 mg, beispielsweise 600 bis 1600 mg, beträgt. Das erfindungsgemässe Verfahren zur Herstellung der neuen Verbindungen der allgemeinen Formel (II) besteht darin, dass man eine ss-Ketosäure der allgemeinen Formel EMI2.2 worin R, Xund die strichlierte Linie die oben angegebene Bedeutung haben, oder ein Salz hievon decarboxyliert, worauf gewünschtenfalls die CO-Gruppe der erhaltenen Verbindung der Formel (11) zu einer CHOHGruppe reduziert wird. Die Decarboxylierung kann in der für $-Ketosäuren üblichen Weise bewirkt werden, beispielsweise durch Erhitzen gegebenenfalls in einem sauren Medium. Die Säuren der Formel (III) können durch Hydrolyse von Äthylestern hievon hergestellt werden, die ihrerseits durch Umsetzen einer Verbindung der Formel CH . CO. CHNa. CO Ät, (IV) mit einer Verbindung der allgemeinen Formel <Desc/Clms Page number 3> EMI3.1 worin R1 und X die oben angegebene Bedeutung haben und B Chlor, Brom, Jod oder eine ähnliche ersetzbare Gruppe bedeutet, oder mit einer Verbindung der allgemeinen Formel EMI3.2 worin R und X die oben angegebene Bedeutung haben, und nachfolgende Dehydratisierung hergestellt werden können. Derartige Reaktionen verlaufen unter üblichen Bedingungen. Pharmakologische Daten Unter Anwendung eines herkömmlichen Allen-Doisy-Tests wurde die östrogene Wirksamkeit bestimmter erfindungsgemäss erhältlicher Verbindungen festgestellt. Die Ergebnisse sind in Tabelle 1 gezeigt. Die entzündungshemmende Wirksamkeit bestimmter erfindungsgemäss erhältlicher Verbindungen wurde unter Anwendung eines Standard-Rattenpfoten-Carrageen-Tests festgestellt, Diese Ergebnisse sind ebenfalls in Tabelle 1 gezeigt. Diese Ergebnisse zeigen, dass die erfindungsgemäss erhältlichen Verbindungen in einer Dosierung ein gutes Ausmass an Aktivität aufweisen, wo eine übermässige Östrogenität nicht zu erwarten war. Weiterhin wird angenommen, dass das Fehlen einer Verzweigung am a-Kohlenstoffatom jede Östrogenität stark reduziert, die vorhanden sein könnte, während es die entzündungshemmende Wirksamkeit der Verbindungen nicht stark berührt. Weiterhin wurde beobachtet, dass Verbindungen der Formel EMI3.3 worin R und die strichlierte Linie die obige Bedeutung haben, den Rattenmagen in einer Dosis von 300 mg/kg/Tag bei oraler Verabreichung nach 3 Tagen nicht übermässig reizen, während am Ende einer 1 1/2 Tage dauernden oralen Behandlung mit der Verbindung der Formel (I) in der gleichen Dosis eine sehr schwere Magenreizung festgestellt wurde. <Desc/Clms Page number 4> Tabelle 1 EMI4.1 <tb> <tb> Verbindung <SEP> Östrogenität <SEP> Entzündungshemmung <tb> Allen-Doisy-Test <SEP> Ratten-Carrageen-Test <SEP> <tb> 3- <SEP> (6'-Methoxy-2'-naphthyl)- <SEP> 50 <SEP> mg/kg <SEP> subkutan, <SEP> inaktiv <SEP> 100 <SEP> mg/kg <SEP> oral, <tb> - <SEP> butan-2-on <SEP> (Maus) <SEP> aktiv <tb> 600 <SEP> mg/kg <SEP> oral, <SEP> inaktiv <tb> (Ratte) <tb> 3-Hydroxy-3-methyl-4- <SEP> (6'- <SEP> 100 <SEP> mg/kg <SEP> subkutan, <SEP> aktiv <SEP> 50 <SEP> und <SEP> 100 <SEP> mg/kg <SEP> oral, <tb> -methoxy-2'-naphthyl)-pentan- <SEP> (Maus) <SEP> aktiv <tb> - <SEP> 2-on <SEP> <tb> 4- <SEP> (6'-Methoxy-2'-naphthyl)- <SEP> 100 <SEP> mg/kg <SEP> subkutan, <SEP> inaktiv <SEP> 100 <SEP> mg/kg <SEP> oral, <tb> - <SEP> pent-3-en-2-on <SEP> (Maus) <SEP> aktiv <tb> 4- <SEP> (6'-Methoxy-2'-naphthyl)-300 <SEP> mg/kg <SEP> oral, <SEP> aktiv <SEP> 300 <SEP> mg/kg, <SEP> oral <tb> - <SEP> pentan-2 <SEP> -on <SEP> (Ratte) <SEP> aktiv <tb> 4-(6'-Methoxy-2'-naphthyl)- <SEP> 200 <SEP> mg/kg <SEP> oral, <SEP> inaktiv <SEP> 50 <SEP> mg/kg <SEP> oral, <tb> - <SEP> pentan-2 <SEP> -on <SEP> (Ratte) <SEP> schwach <SEP> aktiv, <tb> 100 <SEP> mg/kg <SEP> oral, <tb> Aktivität <SEP> 1 <SEP> h <SEP> nach <SEP> Verabreichung <tb> 4-(6'-Methoxy-2'-naphthyl)- <SEP> 300 <SEP> mg/kg <SEP> oral, <SEP> inaktiv <SEP> 300 <SEP> mg/kg <SEP> oral, <tb> -3-huten-2-on <SEP> (Ratte) <SEP> aktiv <tb> *) Aspirin (300 mg/kg) ergibt eine äquivalente Aktivität 2 h nach Verabreichung <Desc/Clms Page number 5> Das folgende Beispiel soll die Erfindung näher erläutern, ohne dass diese jedoch hierauf beschränkt sein soll. Beispiel :4-(6'-Methoxy-2'-naphthyl)-butan-2-on EMI5.1 0, 45 Mol 3-Äthoxycarbonyl-4- (61 -methoxy-21-naphthyl) -butan-2-on in insgesamt 1200 ml Äthanol und 470 ml 5N HCI wurden 7 h unter Rückfluss gehalten, nach welcher Zeit Dünnschichtchromatographie beendete Reaktion anzeigte. Das Äthanol wurde unter vermindertem Druck entfernt, worauf sich ein brauner Feststoff EMI5.2 gen Feststoffes erhalten, der bei Gasschichtchromatographie 70% der im Titel genannten Verbindung enthielt. Durch Kristallisieren aus 80% ÄtOH/H 0 (588 ml) mit Tiefkühlung wurden 56,0 g (54,6%) cremefarbene Mikrokristalle der im Titel genannten Verbindung erhalten, Fp. 78,5 bis 79, 50C, bei Gassehichtchromatographie zu 96% rein. Bei Abdampfen des Lösungsmittels und Kristallisation von 46,6 g des dunklen Rückstandes aus 70 ml Äthanol mit Tiefkühlung wurden weitere 9,2 g (9,0%) Kristalle der im Titel genannten Verbindung erhalten, Fp. 78 bis 79, 5 C, bei Gasschichtehromatographie zu 94% rein. Das Material wurde wieder aus 275 ml Äthanol unter Tiefkühlung kristallisiert, wobei 55,9 g (54,5%) der im Titel genannten Verbindung in Form blasscremefarbener Mikronadeln erhalten wurden, Fp. 80,5 bis 81 C, bei Gasschichtchromatographie zu 97, 7% rein. Das NMR-Spektrum stimmte mit der Struktur überein.
Claims (1)
- PATENTANSPRUCH : Verfahren zur Herstellung von neuen Naphthalinderivaten der allgemeinen Formel EMI5.3 worin X Chlor, Brom, Methoxy, Methylthio oder Alkyl mit 1 bis 4 C-Atomen bedeutet, R Wasserstoff oder EMI5.4 Formel EMI5.5 worin rut, X und die strichlierte Linie die oben angegebene Bedeutung haben, oder ein Salz hievon decarboxy- <Desc/Clms Page number 6> liert, worauf gewünschtenfalls die CO-Gruppe der erhaltenen Verbindung der Formel (11) zu einer CHOHGruppe reduziert wird.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT501276A AT343642B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT501276A AT343642B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT9375A AT338257B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA501276A ATA501276A (de) | 1977-10-15 |
| AT343642B true AT343642B (de) | 1978-06-12 |
Family
ID=3481320
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT501776A AT343103B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT9375A AT338257B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT501276A AT343642B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT501476A AT343643B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthylsubstituierten ketonen |
| AT501576A AT343102B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT501876A AT343104B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT501676A AT344152B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT501176A AT344151B (de) | 1975-01-08 | 1976-07-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT501776A AT343103B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT9375A AT338257B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT501476A AT343643B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthylsubstituierten ketonen |
| AT501576A AT343102B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT501876A AT343104B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT501676A AT344152B (de) | 1975-01-08 | 1975-01-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
| AT501176A AT344151B (de) | 1975-01-08 | 1976-07-08 | Verfahren zur herstellung von neuen naphthalinderivaten |
Country Status (1)
| Country | Link |
|---|---|
| AT (8) | AT343103B (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2407907A1 (fr) * | 1977-11-03 | 1979-06-01 | Beecham Group Ltd | Derives du naphtalene utilisables comme medicament |
| NL8700356A (nl) * | 1986-02-15 | 1987-09-01 | Beecham Group Plc | Nieuwe werkwijze. |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8603777D0 (en) * | 1986-02-15 | 1986-03-19 | Beecham Group Plc | Chemical process |
| GB8603768D0 (en) * | 1986-02-15 | 1986-03-19 | Beecham Group Plc | Process |
| GB8707200D0 (en) * | 1987-03-26 | 1987-04-29 | Beecham Group Plc | Chemical process |
| AU5656698A (en) * | 1996-12-03 | 1998-06-29 | Recordati S.A. Chemical And Pharmaceutical Company | A process for the preparation of nabumetone |
| DE202009002071U1 (de) | 2009-04-17 | 2010-09-02 | Paul Hettich Gmbh & Co. Kg | Dämpfer für Möbel |
-
1975
- 1975-01-08 AT AT501776A patent/AT343103B/de not_active IP Right Cessation
- 1975-01-08 AT AT9375A patent/AT338257B/de not_active IP Right Cessation
- 1975-01-08 AT AT501276A patent/AT343642B/de not_active IP Right Cessation
- 1975-01-08 AT AT501476A patent/AT343643B/de not_active IP Right Cessation
- 1975-01-08 AT AT501576A patent/AT343102B/de not_active IP Right Cessation
- 1975-01-08 AT AT501876A patent/AT343104B/de not_active IP Right Cessation
- 1975-01-08 AT AT501676A patent/AT344152B/de not_active IP Right Cessation
-
1976
- 1976-07-08 AT AT501176A patent/AT344151B/de not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2407907A1 (fr) * | 1977-11-03 | 1979-06-01 | Beecham Group Ltd | Derives du naphtalene utilisables comme medicament |
| NL8700356A (nl) * | 1986-02-15 | 1987-09-01 | Beecham Group Plc | Nieuwe werkwijze. |
Also Published As
| Publication number | Publication date |
|---|---|
| AT344151B (de) | 1978-07-10 |
| ATA501876A (de) | 1977-09-15 |
| ATA501476A (de) | 1977-10-15 |
| AT344152B (de) | 1978-07-10 |
| AT338257B (de) | 1977-08-10 |
| AT343103B (de) | 1978-05-10 |
| AT343104B (de) | 1978-05-10 |
| ATA501276A (de) | 1977-10-15 |
| AT343102B (de) | 1978-05-10 |
| AT343643B (de) | 1978-06-12 |
| ATA9375A (de) | 1976-12-15 |
| ATA501676A (de) | 1977-11-15 |
| ATA501176A (de) | 1977-11-15 |
| ATA501776A (de) | 1977-09-15 |
| ATA501576A (de) | 1977-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1643224B2 (de) | 1 -Phenyl-2-aminoäthanolderivate und deren Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2557497A1 (de) | Neue tryptophanderivate mit erhoehter wirkung auf das zentralnervensystem | |
| DE2163911B2 (de) | 2-Aminomethyl-phenole, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel | |
| AT343642B (de) | Verfahren zur herstellung von neuen naphthalinderivaten | |
| DE1940566C3 (de) | 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel | |
| DE2723051B2 (de) | N^AcyO-p-amino-N'-Oi-decyl- und n-tridecyO-benzamide sowie diese enthaltende Arzneimittel | |
| DE2221758A1 (de) | Yohimbinderivate,Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE1915230C3 (de) | Hydroxyphenylalkylaminderivate, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis | |
| DE2428200A1 (de) | Essigsaeurederivate, verfahren zu deren herstellung und diese derivate enthaltende arzneimittel | |
| DE3121175A1 (de) | Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE2800015A1 (de) | Neue chromderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| DE2336671A1 (de) | Oxyessigsaeureaether von o-thymotinsaeureestern | |
| DE2640884A1 (de) | Neue entzuendungshemmende l-oxo-isoindolin-derivate und verfahren zu ihrer herstellung | |
| DE2004301A1 (de) | Phenylserinderivate | |
| DE1931927A1 (de) | Neue Cyclohexylaminderivate | |
| DD142875A5 (de) | Verfahren zur herstellung von 2-aminoaethanolderivaten | |
| DE1793828C3 (de) | 2-(6'-Fluor-2'-naphthyl)-propionsäureamid und dessen Herstellung und Verwendung | |
| AT212322B (de) | Verfahren zur Herstellung von neuen Pyridazinon-Derivaten | |
| AT360990B (de) | Verfahren zur herstellung des neuen 1-methyl-4- (3-carboxy-10,11-dihydro-5h-dibenzo-(a,d)- -cyclohepten-5-yliden)-piperidin (10,11-dihydro -3-carboxy-cyproheptadin), seines n-oxids und seiner salze | |
| AT343645B (de) | Verfahren zur herstellung von neuen indanylcarbonsauren und deren salzen | |
| AT366047B (de) | Verfahren zur herstellung von neuen chinazolinderivaten und deren salzen | |
| AT360016B (de) | Verfahren zur herstellung des neuen 1-methyl-4- (3-carboxy-10,11-dihydro-5h-dibenzo-(a,d)- cyclohepten-5-yliden)-piperidin (10,11-dihydro- -3-carboxy-cyproheptadin), seines n-oxids und seiner salze | |
| DE3008852A1 (de) | Benzodiazepinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE1420955C (de) | alpha (o Benzylphenoxy)-beta piperidino propan, dessen Saureadditionssalze sowie Verfahren zur Herstellung dieser Verbm düngen | |
| AT329021B (de) | Verfahren zur herstellung von neuen sulfamylbenzoesauren sowie deren pharmazeutisch annehmbaren salzen und estern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELA | Expired due to lapse of time | ||
| ELJ | Ceased due to non-payment of the annual fee |